Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

Sleep apnea “occurs when a person’s upper ... The approval of Zepbound follows a series of other weight loss drugs approved to treat medical conditions other than obesity and diabetes.

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

Obstructive sleep apnea occurs when a person’s upper ... Medicare does not cover weight-loss drugs specifically for obesity, although the medications can be covered for conditions exacerbated ...

So it makes sense that weight loss drugs like Eli LIlly’s Zepbound are being explored as alternatives to traditional obstructive sleep apnea therapies. Dr. Glickman echoes this insight ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea ... which doesn't cover drugs solely for weight loss.Without insurance coverage ...

The FDA approval comes amid growing discussion about the potential uses of weight loss drugs beyond treating obesity and diabetes. In addition to sleep apnea, there has been increasing interest in ...